SCHEMBL11084332

SCHEMBL11084332

CCCCCCCC(=O)C=[N+]=[N-]

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.67
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48
TRPA1 O75762 1/20 0.47
HSP90AA1 P07900 1/20 0.47
GPR84 Q9NQS5 7/20 0.46
PPARG P37231 7/20 0.46
PPARD Q03181 7/20 0.46
PPARA Q07869 7/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
PTPN1 P18031 3/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
MEN1 O00255 1/20 0.46
ESR1 P03372 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6893226 1.00 FAAH (0.67) FAAHCES2CES1TRPA1HSP90AA1
SCHEMBL11081119 1.00 FAAH (0.67) FAAHCES2CES1TRPA1HSP90AA1
SCHEMBL11090505 1.00 FAAH (0.67) FAAHCES2CES1TRPA1HSP90AA1
SCHEMBL13163885 1.00 FAAH (0.67) FAAHCES2CES1TRPA1HSP90AA1
SCHEMBL6256065 1.00 FAAH (0.67) FAAHCES2CES1TRPA1HSP90AA1
SCHEMBL23113780 0.98 FAAH (0.69) FAAHCES2CES1TRPA1HSP90AA1
SCHEMBL11082182 0.91
SCHEMBL6897603 0.91 FAAH (0.82) FAAHPPARGPPARDPPARAPTPN1
SCHEMBL5974543 0.91 FAAH (0.82) FAAHPPARGPPARDPPARAPTPN1
SCHEMBL6264472 0.89 FAAH (0.52) FAAHTRPA1HSP90AA1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4489091-A ESTERASE AND ANTIBODY INHIBITORS TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 1984-12-18 US disclosed
US-4411911-A Method of treating hyperlipidemia and inflammation with sulfonate derivatives TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1983-10-25 US disclosed